 Home > Pharmaceutical Intermediates > Bulk Drug Intermediates > RT10 Retatrutide 10mg for Sale > RT10 Retatrutide 10mg

RT10 Retatrutide 10mg buy - large image1

RT10 Retatrutide 10mg

Name: RT10 Retatrutide 10mg
SKU: pr2608181949
Price: 65 USD
Availability: InStock

Unit Price:

$65-75/MT EXW

Get Latest Price 

Grade:

Pharmaceutical Grade

Content:

99%

Port:

SHENZHEN

Packaging:

10 vials /box

Price valid (until):

2027-09-01

Contact Supplier

 Chat Now

TONGQI FUTYRE LIMITED

Company Type:

Trader

Location:

Hongkong, China

Qualification:

Main Products:

Retatrutide

 Visit Store

Product Description
Seller Information

Description

Contact information

Name：Iris

Email：Xb20050416@gmail.com

WhatsApp：+852 6391 4517

Company Information

Our company specializes in exporting various chemical products, including chemical raw materials, a full range of peptide products.

We will provide you with high quality products at the best offer. Professional transportation, convenient and safe, door-to-door delivery.

Customers who have ordered our products（peptides）have had very good feedback.

World wide relaible buyers can contact us about the peptides.

Product Image

Packaging and Shipping

FAQ

Q1: About the after-sale service

A: After purchasing the products from our Lab, we have A professional technical team and after-sales team to serve you and solve all your problems in the future

Q2: What is your MOQ?
A: The minimum quantity we can order is 1 box.

Basic Info

Product Name:
RT10 Retatrutide 10mg

Categories:
Bulk Drug Intermediates

Research

Class:
Triple agonist — GCGR, GIPR, GLP-1R

Status:
Investigational (Phase 3)

Mechanism:
Simultaneously activates glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R). Engineered from the native GIP backbone with amino acid substitutions to confer GCGR and GLP-1R activity.

EC50 (Human GCGR):
5.79 nM

EC50 (Mouse GIPR):
0.191 nM

EC50 (Mouse GLP1R):
0.794 nM

EC50 (Mouse GCGR):
2.32 nM

EC50 (Human GLP1R):
0.775 nM

EC50 (Human GIPR):
0.0643 nM

Source:
Jastreboff AM, et al. N Engl J Med. 2023;389(6):514-526.DOI

Clinical Development:
NCT04881760; NCT05882045; NCT06354660

References

ChEMBL:
CHEMBL5095485

DrugBank:
DB18993

KEGG DRUG:
D12430

PubChem:
PubChem

Literature:
NEJM: Jastreboff et al. (2023) — Phase 2 Trial; FDA Drugs@FDA

Disclaimer:
Retatrutide is an investigational compound not yet approved by FDA or EMA. This listing is for industrial and laboratory research use only. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.
Seller Information

Business Type:
Trader

Main Products:
Retatrutide

Location:
B27 SHING LEE COMM BLDG 8 WING KUT ST CENTRAL HONG KONG

Year of Establishment:
2026
Country Product Purchase Quantity Date Posted

Post an enquiry for this product

RT10 Retatrutide 10mg

Product Description

Seller Information

Related Products

Related Searches

More from this Seller